We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Tick up 6.35
Looking strong here today
I posted this on June 7th.
Just found this video on YouTube. I'm sure some will have seen it, however now someone has suggested Pfizer it seems to make sense. I really like this lady executives style. What she says rings bells and as far as I'm concerned Pfizer are now my leading contender. It must be said Hemo will only get paid on results or maybe be could start a pet shop with all those mice.( Joking)
We are heading for a new world of medical treatments and we have a place on the grid. Race is on.
https://m.youtube.com/watch?v=iQmTLf1tSZA
IMO GLA
Yes spot on, and according to https://pubmed.ncbi.nlm.nih.gov/31981494/ That stage is complete...
Next stage is HUMAN TRIALS.
Clear implication that some tests have been carried out on monkeys, and that the next step was monkeys.
Re: monkeys you might want to watch the last 4-5 minutes of this presentation from November.
https://www.youtube.com/watch?v=WK9FrOukj-w
ok own up... who told everyone??? Good to see us 7.5% up already
As the deal is close now..just wondering what other investors
think will be agreed??
Nope no MM signals, this I think caught everyone on the back foot, I suspect there will be some large orders placed with MMs today but not sure how it will play out if they cant panic shake sells?
Going to be interesting, I really cant see anyone selling when they know 24m mcap Hemo is partnered up with Pfizer lol!
@JHFH ok understood, I appreciate the explanation
Any more of those 1,2,3,4,5 signals JHFH? Very helpful last time you identified a signal. Plus great article find. Thanks Asleep
Scart they will have used mice and some monkeys, probably some regulations that it has to go through monkeys first before it can move to human trials. But that was done by themselves, we had already proven it all works with the mice before Pfizer signed the first contract.
Pfizer/Hemo
Interesting.
Be nice to get back in the teens again here....they were the days!
gla
@JHFH is it odd that it "exhibited potent efficacy in cynomolgus monkeys" rather than testing on mice? Although from HEMO's RNS it looks like humanised mice were the next stage...
https://youtu.be/IJB5hdWykj0
https://twitter.com/pfizer/status/1278054845912621057?s=20
It's pretty much the same wording...
@JHFH nice and great find, thank you!
Now... can everyone please keep quiet about it because I've not got the funds available to top up here yet... much appreciated :-)
come one my son
Looks like it may well be Pfizer...would be great news...
One of the world's largest Pharmaceuticals...
Good blue start to the day...GLA!
@Scart in relation to this particular article, no I am not sure why it has not been found before, but back 15th Jan it was not connected directly to Pfizer, not sure if the link I provided was not around back then or not, if it had been there would not have been any debate about who Global Co is
Hemo Californication. Be sure to wear some flowers in your hair. ;-)
There has been speculation about Pfizer for a while, but last night I found as solid evidence as you can hope to find.
Basically they have published a paper where Pfizer scientists and staff are taking complete ownership and credit for Hemogenyx CDX AML candidate. No question about option to licence etc, its black and white going forward as a Pfizer product. It also states recommend to move to clinical trials.
Now that also means Pfizer are taking the Lupus treatment and are working with our mice.
Pfizer yesterday announced fast progress with a Covid-19 vaccine, where do you think it was also tested?
@JHFH that was published on 13 Jan 2020 by Pfizer and I assume is what prompted this RNS on 15 Jan by HEMO https://www.lse.co.uk/rns/HEMO/hemos-car-t-cells-effective-against-aml-in-vitro-scfjdxpqlgxz76t.html
Was there speculation about Pfizer back then too? Sorry not been here as long as that. Seems strange to not have been noted as Pfizer all along given that obvious connection...
The charge to be taken over very high .if that happens share price will be multiple time now . One more month we will know that
The below information was removed 3 days later from the Hemogenyx website after I mentioned a possible connection with Pfzier.
Dr Boris Shor Ph.D
BUSINESS DEVELOPMENT ADVISOR
Currently a group leader at the Oncology Research Unit of Pfizer in New York. His team focuses on the discovery and early development of new antibody-drug conjugates (ADCs) and supports translational research efforts for the late stage assets. Dr. Shor also serves as a nonclinical pharmacology representative on the late stage clinical program, supporting BLA filings with worldwide regulatory authorities. In addition, Dr. Shor is routinely involved in accessing emerging sciences, R&D technology platforms and therapeutic products in US, Israel and Europe to ensure strategic integration of external opportunities in disease areas of interests to Pfzier.
This should be enough, if you cannot read sell your shares:
https://pubmed.ncbi.nlm.nih.gov/31981494/